Delivery Order SPE2DB24D1205-SPE2DB25FCWYP

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $31,195.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tolvaptan 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization and a registered vendor in the System for Award...
This federal contract award, valued at $13,691.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tolvaptan 15 mg tablets, a medication used to treat certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance extending to July 15, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,201.22 Firm Fixed Price Delivery Order contract is for the supply of 4567443505 - TOLVAPTAN 15 MG TABLET UD 10S. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,444.55 firm fixed price contract is for the delivery of 10-count units of the 30 mg Tolvaptan tablet medication. The delivery order has a completion date of May 22, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $7,674.04 and a period of performance running through March 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a medication, with a ceiling value of $13,468.19 and a performance period ending on May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,282.57, is for the delivery of 4567618547 TOLVAPTAN 30 MG TABLET UD 10S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 19, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award, with the ID SPE2DX15D1022|SPE2DX25FVBVS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $38,084.10 fixed-price delivery order is for the supply of 4567111758 TOLVAPTAN 15 MG TABLET UD 10S, with a period of performance through February 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,749.40 firm-fixed-price contract is for the supply of TOLVAPTAN 15 MG TABLET UD 10S, a pharmaceutical product. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $10,623.60 firm fixed-price delivery order contract is for the supply of SAMSCA 15 MG TABLET 10S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025 and was awarded on May 22, 2025. The award is not designated as a set-aside and represents an open competition....
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWYP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Tolvaptan 15 mg tablets, a medication, with a ceiling value of $32,564.52 and a completion date of May 21, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 12:56 AM